Joshua D. Rosenblat

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

David Chen-Li

IQVIA

CANADA

View details

Gary Rodin

University Health Network

CANADA

View details

Hartej Gill

University of Toronto

CANADA

View details

Roger S. McIntyre

University Health Network

CANADA

View details

Swainson Jennifer

University of Alberta

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joshua D. Rosenblat

Research Interests

Explore related searches

Contact this professor

Articles (21)

Effect of intravenous ketamine on suicidality in adults with treatment-resistant depression: A real world effectiveness study

Real world effectiveness of maintenance ketamine infusions for treatment-resistant depression in major depressive disorder and bipolar disorder

Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence

Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)

Pentoxifylline for bipolar depression: A pilot study

Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties

Mechanisms of psilocybin on the treatment of posttraumatic stress disorder

A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists

Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review

Ketamine for bipolar depression: an updated systematic review

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic Review

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study

Pharmacogenomics of ketamine: A systematic review

A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat

A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions

Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review

Barriers, benefits and interventions for improving the delivery of telemental health services during the coronavirus disease 2019 pandemic: a systematic review

Collaborators (5)

David Chen-Li

Gary Rodin

Hartej Gill

Roger S. McIntyre

Swainson Jennifer

Make your next move.